SCHEMBL7392131

SCHEMBL7392131

[c]1cccc(-c2cccnc2)c1Cn1ccnc1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 17/20 0.51
▸ CYP11B2 P19099 15/20 0.51
▸ CYP17A1 P05093 1/20 0.43
▸ CYP19A1 P11511 3/20 0.41
▸ TBXAS1 P24557 2/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ QPCT Q16769 1/20 0.41
▸ CYP4Z1 Q86W10 1/20 0.41
▸ QPCTL Q9NXS2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7390725 0.88 CYP11B1 (0.62) CYP11B1CYP11B2CYP17A1CYP19A1TBXAS1
SCHEMBL7389176 0.80 CYP19A1 (0.47) CYP11B1CYP11B2CYP17A1CYP19A1TBXAS1
SCHEMBL6637618 0.77 CHRNB2 (0.50) —
SCHEMBL7385735 0.77 CHRNB2 (0.47) CYP1A2CYP3A4
SCHEMBL7391276 0.76 CYP11B1 (0.47) CYP11B1CYP11B2CYP17A1CYP19A1TBXAS1
SCHEMBL7391205 0.76 CHRNB2 (0.49) CYP2D6
SCHEMBL7395139 0.74 MKNK1 (0.43) CYP1A2CYP3A4CYP2D6
SCHEMBL8195408 0.73 CYP2A6 (0.41) CYP11B1CYP11B2CYP19A1CYP1A2CYP3A4
SCHEMBL6331673 0.72 CYP2A6 (0.48) CYP11B1CYP1A2CYP3A4CYP2D6MAPT
SCHEMBL7952212 0.70 CYP2A6 (0.49) CYP11B1CYP11B2CYP17A1CYP19A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6060491-A ANTICOAGULANTS; THROMBOEMBOLIC DISORDERS; PROPHYLAXIS DUPONT PHARMACEUTICALS (US) 2000-05-09 — — US disclosed
EP-0993448-A1 (AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 2000-04-19 — — EP disclosed
US-5998424-A ANTICOAGULANTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-12-07 — — US disclosed
WO-1998057934-A1 (AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-23 — — WO disclosed
Send feedback